(PDF) Pmh6 - Lurasidone Induced Suicidal Ideation and

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.1643

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

English

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Proceedings for Annual Meeting of The Japanese Pharmacological Society

2020

English

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

English

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

English

Prm87 - Critical Evaluation of Various Data Mining Algorithms Used for Signal Detection in Fda Adverse Event Reporting System Database

English

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

English

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

Clinical Pharmacology and Therapeutics

Pharmacology

2013

English

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

Journal of Bone and Joint Surgery - Series A

English

Amanote Research

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.1643

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

Prm87 - Critical Evaluation of Various Data Mining Algorithms Used for Signal Detection in Fda Adverse Event Reporting System Database

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts